月经症候群治疗市场规模、份额、成长分析（按产品、药物类型、分销管道和地区）- 产业预测（2025-2032）

预计2023年全球月经症候群治疗市值将达13.9亿美元，2032年将成长至18.9亿美元，预测期间（2025-2032年）的复合年增长率为3.42%。

全球月经症候群 (PMS) 治疗市场正在成长，这得益于人们对 PMS 及其对女性健康影响的认识不断提高，以及对有效治疗方案的需求不断增加。随着医疗保健趋势强调个人化和非侵入性方法，人们明显转向非荷尔蒙和综合治疗。市场的主要参与者是知名的製药和医疗保健公司，他们投资于研发以推出创新治疗方法。然而，挑战依然存在，包括延长治疗机会的监管障碍和缺乏标准化的治疗通讯协定，导致患者的治疗结果不一致。包括 PMS 追踪应用程式在内的数位健康解决方案的整合引发了人们对资料隐私和安全的担忧，凸显了随着行业不断发展，对强有力资料保护的必要性。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 顾客购买行为分析

月经症候群治疗市场规模（依产品及复合年增长率） (2025-2032)

• 市场概览
• 处方笺
• 非处方药

月经症候群治疗市场规模（依药物类型及复合年增长率） (2025-2032)

• 市场概览
• 止痛药
• 抗忧郁症
• 口服避孕药和卵巢抑制剂

月经症候群治疗市场规模（依分销管道及复合年增长率） (2025-2032)

• 市场概览
• 药局和药房
• 医院药房
• 网路药局

月经症候群治疗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 按部门分類的公司份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Bayer AG
• Eli Lilly and Company
• GlaxoSmithKline Plc
• Pfizer Inc.
• AbbVie Inc.
• H. Lundbeck A/S
• Dr. Reddy's Laboratories Ltd
• BASF SE
• SHIONOGI & Co. Ltd
• Asarina Pharma AB
• Teva Pharmaceutical Industries Ltd
• Vistagen Therapeutics
• Herbalife International of America, Inc.
• The Nature's Bounty Co.
• Johnson & Johnson Services

结论和建议

Global Premenstrual Syndrome Treatment Market size was valued at USD 1.39 Billion in 2023 and is poised to grow from USD 1.44 Billion in 2024 to USD 1.89 Billion by 2032, growing at a CAGR of 3.42% in the forecast period (2025-2032).

The global premenstrual syndrome (PMS) treatment market is experiencing growth driven by heightened awareness of PMS and its impact on women's health, coupled with a demand for effective treatment options. There is a noticeable shift toward non-hormonal and integrative treatments, aligning with broader healthcare trends emphasizing personalization and non-invasive methods. Key players in the market comprise prominent pharmaceutical and healthcare companies investing in research and development to introduce innovative therapies. However, challenges persist, such as regulatory hurdles that prolong treatment accessibility and a lack of standardized treatment protocols, resulting in varied patient outcomes. The integration of digital health solutions, including PMS tracking apps, raises concerns about data privacy and security, underscoring the necessity for robust data protection as the industry continues to evolve.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Premenstrual Syndrome Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Premenstrual Syndrome Treatment Market Segments Analysis

The global premenstrual syndrome treatment market is segmented into product, drug, distribution channel, and region. by product, the market is classified into Prescription and Over-the-Counter (OTC). Depending on the drug, it is divided into Analgesics, Antidepressants, and Oral Contraceptives & Ovarian Suppression Agents. According to distribution channel, the market is categorized into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Premenstrual Syndrome Treatment Market

The growing awareness of premenstrual syndrome (PMS) through public education initiatives and awareness campaigns has significantly boosted diagnosis rates, leading to a heightened demand for treatments. Efforts by organizations focused on PMS have played a crucial role in informing women about the condition and its symptoms, encouraging them to seek medical assistance. This increased understanding not only helps women manage their symptoms more effectively but also drives the market for various treatments, including oral contraceptives, as more individuals become proactive in addressing their health needs related to PMS. This trend is crucial in expanding the overall premenstrual syndrome treatment market.

Restraints in the Global Premenstrual Syndrome Treatment Market

The Global Premenstrual Syndrome Treatment market faces significant restraints due to the stigma surrounding mental health issues associated with PMS and the prevalent underreporting of symptoms. In various cultures, there exists a taboo that discourages open discussions among women regarding their experiences and symptoms, which subsequently leads to a decreased demand for treatment options such as antidepressants and hormonal therapies. This lack of awareness and unwillingness to seek help hampers the overall growth potential of the market, as many individuals may not pursue the necessary interventions to alleviate their discomfort and improve their quality of life.

Market Trends of the Global Premenstrual Syndrome Treatment Market

The Global Premenstrual Syndrome (PMS) Treatment market is witnessing a significant shift towards natural and holistic solutions, as consumers increasingly prioritize plant-based remedies over conventional pharmaceuticals. This trend reflects a growing awareness of wellness and the desire for sustainable treatment options. Herbal supplements rich in vitamin B6, calcium, and magnesium are becoming popular choices for alleviating PMS symptoms like cramping and mood swings. As wellness trends continue to flourish, businesses that offer herbal and plant-based treatments are capitalizing on this demand, positioning themselves favorably within a market that seeks effective, drug-free solutions to improve women's health.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Premenstrual Syndrome Treatment Market Size by Product & CAGR (2025-2032)

• Market Overview
• Prescription
• Over-the-Counter (OTC)

Global Premenstrual Syndrome Treatment Market Size by Drug Type & CAGR (2025-2032)

• Market Overview
• Analgesics
• Antidepressants
• Oral Contraceptives & Ovarian Suppression Agents

Global Premenstrual Syndrome Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Drug Stores & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Premenstrual Syndrome Treatment Market Size & CAGR (2025-2032)

• North America (Product, Drug Type, Distribution Channel)
  • US
  • Canada
• Europe (Product, Drug Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Drug Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Drug Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Drug Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• H. Lundbeck A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SHIONOGI & Co. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asarina Pharma AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vistagen Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife International of America, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Nature's Bounty Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations